HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats

In the human genome, dinucleotide repeats are common sequence elements of unknown functional significance. Here we demonstrate that CA repeats in intron 13 of the human endothelial nitric oxide synthase (eNOS) gene function as an unusual intronic splicing enhancer, whose activity depends on the CA repeat number. We identify the 65 kDa heterogenous nuclear ribonucleoprotein (hnRNP) L as the major factor that binds specifically and in a length-dependent manner to the CA-repeat enhancer. In addition, we show that hnRNP L functions as a specific activator of eNOS splicing, providing the first evidence for a role of hnRNP L in the regulation of mRNA splicing. We hypothesize that hnRNP L may be involved in the regulation of many other genes containing CA repeats or A/C-rich enhancers.

[1]  M. Green,et al.  An ordered pathway of snRNP binding during mammalian pre‐mRNA splicing complex assembly. , 1987, The EMBO journal.

[2]  J. Mertz,et al.  HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression. , 1995, Genes & development.

[3]  D. Cooper,et al.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.

[4]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[5]  B. Chabot.  Directing alternative splicing: cast and scenarios. , 1996, Trends in genetics : TIG.

[6]  V. Pravica,et al.  CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. , 1999, Human immunology.

[7]  F. Welch,et al.  Causes and Consequences , 2017, Nature.

[8]  S. D. Fraser,et al.  The RNA binding protein YB‐1 binds A/C‐rich exon enhancers and stimulates splicing of the CD44 alternative exon v4 , 2001, The EMBO journal.

[9]  J. Valcárcel,et al.  Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.

[10]  G. Dreyfuss,et al.  A novel heterogeneous nuclear RNP protein with a unique distribution on nascent transcripts , 1989, The Journal of cell biology.

[11]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[12]  Yoon Ki Kim,et al.  Heterogeneous Nuclear Ribonucleoprotein L Interacts with the 3′ Border of the Internal Ribosomal Entry Site of Hepatitis C Virus , 1998, Journal of Virology.

[13]  U. Walter,et al.  NO at work , 1994, Cell.

[14]  William Arbuthnot Sir Lane,et al.  Rabbit beta-globin is extended beyond its UGA stop codon by multiple suppressions and translational reading gaps. , 1998, Biochemistry.

[15]  K. Zänker,et al.  Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1* , 1999, The Journal of Biological Chemistry.

[16]  B. Blencowe.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.

[17]  T. Cooper,et al.  Identification of a new class of exonic splicing enhancers by in vivo selection , 1997, Molecular and cellular biology.

[18]  K. Kidd,et al.  Allele Frequencies in a Worldwide Survey of a CA Repeat in the First Intron of the CFTR Gene , 1999, Human Heredity.

[19]  Yusuke Nakamura,et al.  Dinucleotide repeat polymorphism in the first intron of the CSR gene , 1998, Journal of Human Genetics.

[20]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[21]  A. Krainer,et al.  Listening to silence and understanding nonsense: exonic mutations that affect splicing , 2002, Nature Reviews Genetics.

[22]  M. Laule,et al.  High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. , 2000, Pharmacogenetics.

[23]  L. Rothblum,et al.  Rapid, small-scale RNA isolation from tissue culture cells. , 1991, BioTechniques.

[24]  M. Lathrop,et al.  Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. , 1994, Biochemical and biophysical research communications.

[25]  K. Claffey,et al.  Regulation of Human Vascular Endothelial Growth Factor mRNA Stability in Hypoxia by Heterogeneous Nuclear Ribonucleoprotein L* , 1999, The Journal of Biological Chemistry.

[26]  T. Cooper,et al.  The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.

[27]  A. Hajeer,et al.  In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.